Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19

•Polyunsaturated fatty acids and the ratio of arachidonic acid to eicosopentaenoic acid, like interleukin-6, are markers of inflammation in people with COVID-19.•The ratio of arachidonic acid to eicosopentaenoic acid showed a significant positive correlation with only interleukin-6.•Levels of γ-lino...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrition (Burbank, Los Angeles County, Calif.) Los Angeles County, Calif.), 2022-04, Vol.96, p.111581-111581, Article 111581
Hauptverfasser: Sertoglu, Erdim, Yucel, Cigdem, Balık, Ahmet Rıfat, Taşçı, Cantürk, Bilge, Sedat, Ertuğrul, Meryem Sebla, Nazaroğlu, Namık Kemal, Ozgurtas, Taner
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111581
container_issue
container_start_page 111581
container_title Nutrition (Burbank, Los Angeles County, Calif.)
container_volume 96
creator Sertoglu, Erdim
Yucel, Cigdem
Balık, Ahmet Rıfat
Taşçı, Cantürk
Bilge, Sedat
Ertuğrul, Meryem Sebla
Nazaroğlu, Namık Kemal
Ozgurtas, Taner
description •Polyunsaturated fatty acids and the ratio of arachidonic acid to eicosopentaenoic acid, like interleukin-6, are markers of inflammation in people with COVID-19.•The ratio of arachidonic acid to eicosopentaenoic acid showed a significant positive correlation with only interleukin-6.•Levels of γ-linolenic acid and the ω-6/ω-3 ratio were significantly increased in all comparison groups.•The ω-3 index showed a moderately negative correlation with interleukin-6. The cytokine storm presented in the hyperimmune response is related to poor prognosis in people with COVID-19. Interleukin-6 (IL-6) is one of the most prominent cytokines, especially on mucosal surfaces during infection, causing the cytokine storm. Polyunsaturated fatty acids (PUFAs) are the precursors of eicosanoids, which play critical roles in immune regulation and inflammation. The balance between ω-3 and ω-6 levels in the cell membrane has a critical role in regulating the equilibrium between proinflammatory and antiinflammatory processes and inducing IL-6 production. The present study focused on inflammatory and antiinflammatory mechanisms in COVID-19 over PUFAs and on relating their levels with disease prognosis and severity. A total of 106 participants were included in the study. They were divided into three groups according to IL-6 level— 1: 300 pg/mL. Erythrocyte membrane PUFA compositions were analyzed by group. Levels of γ-linolenic acid and ω-6/ω-3 ratios were significantly increased in all comparison groups (P < 0.05). Total ω-6 and the ratio of arachidonic acid to eicosopentaenoic acid showed a statistically significant difference only between groups 1 and 3 (P < 0.05). There was a moderately negative correlation between total ω-3 and IL-6 and procalcitonin. There were positive correlations with ω-6/ω-3 ratio inflammatory markers, and the total ω-6 index also showed a moderately positive correlation with IL-6, procalcitonin, and D-dimer levels. The ratio of arachidonic acid to eicosopentaenoic acid, and ω-3 PUFAs, can be systemic signs of poor prognosis, increased lung damage, and high mortality in COVID-19, together with IL-6.
doi_str_mv 10.1016/j.nut.2021.111581
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8710241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0899900721004433</els_id><sourcerecordid>2624660149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-8df144c5e906b81074cc2fb60455762513e19892cf38ff27f10e5ef263f5dcdc3</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS1ERZfCD-CCInHhkq3HcZxYSEhoW6BSpV6Aq-V1xqyXJF5sZ6s99L_XS0oFHDhZGn_vaeY9Ql4BXQIFcb5djlNaMspgCQB1C0_IAtqmKoFx_pQsaCtlKSltTsnzGLeUUpBCPiOnVZ31LbAFubvc637Syfmx8LbAcEib4M0hYTHgsA56xMLqlA6lNq4rjB92ProjHgs3FjpGb9wsv3Vpk2cJQ4_TDzeWouhxj_0vcJcZHFOcqdXNt6uLEuQLcmJ1H_Hlw3tGvn68_LL6XF7ffLpafbguDW9kKtvOAuemRknFugXacGOYXQvK67oRrIYKQbaSGVu11rLGAsUaLROVrTvTmeqMvJ99d9N6wM7kTYLu1S64QYeD8tqpv39Gt1Hf_V61DVDGIRu8fTAI_ueEManBRYN9n_PxU1RMMC4EBS4z-uYfdOunMObzMlU1FVDKRaZgpkzwMQa0j8sAVcdy1VblctWxXDWXmzWv_7ziUfG7zQy8m4EcOu4dBhVNTt1g5wKapDrv_mN_D7eUtus</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2637310046</pqid></control><display><type>article</type><title>Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Sertoglu, Erdim ; Yucel, Cigdem ; Balık, Ahmet Rıfat ; Taşçı, Cantürk ; Bilge, Sedat ; Ertuğrul, Meryem Sebla ; Nazaroğlu, Namık Kemal ; Ozgurtas, Taner</creator><creatorcontrib>Sertoglu, Erdim ; Yucel, Cigdem ; Balık, Ahmet Rıfat ; Taşçı, Cantürk ; Bilge, Sedat ; Ertuğrul, Meryem Sebla ; Nazaroğlu, Namık Kemal ; Ozgurtas, Taner</creatorcontrib><description>•Polyunsaturated fatty acids and the ratio of arachidonic acid to eicosopentaenoic acid, like interleukin-6, are markers of inflammation in people with COVID-19.•The ratio of arachidonic acid to eicosopentaenoic acid showed a significant positive correlation with only interleukin-6.•Levels of γ-linolenic acid and the ω-6/ω-3 ratio were significantly increased in all comparison groups.•The ω-3 index showed a moderately negative correlation with interleukin-6. The cytokine storm presented in the hyperimmune response is related to poor prognosis in people with COVID-19. Interleukin-6 (IL-6) is one of the most prominent cytokines, especially on mucosal surfaces during infection, causing the cytokine storm. Polyunsaturated fatty acids (PUFAs) are the precursors of eicosanoids, which play critical roles in immune regulation and inflammation. The balance between ω-3 and ω-6 levels in the cell membrane has a critical role in regulating the equilibrium between proinflammatory and antiinflammatory processes and inducing IL-6 production. The present study focused on inflammatory and antiinflammatory mechanisms in COVID-19 over PUFAs and on relating their levels with disease prognosis and severity. A total of 106 participants were included in the study. They were divided into three groups according to IL-6 level— 1: &lt;35 pg/mL, 2: between 35 and 300 pg/mL, and 3: &gt;300 pg/mL. Erythrocyte membrane PUFA compositions were analyzed by group. Levels of γ-linolenic acid and ω-6/ω-3 ratios were significantly increased in all comparison groups (P &lt; 0.05). Total ω-6 and the ratio of arachidonic acid to eicosopentaenoic acid showed a statistically significant difference only between groups 1 and 3 (P &lt; 0.05). There was a moderately negative correlation between total ω-3 and IL-6 and procalcitonin. There were positive correlations with ω-6/ω-3 ratio inflammatory markers, and the total ω-6 index also showed a moderately positive correlation with IL-6, procalcitonin, and D-dimer levels. The ratio of arachidonic acid to eicosopentaenoic acid, and ω-3 PUFAs, can be systemic signs of poor prognosis, increased lung damage, and high mortality in COVID-19, together with IL-6.</description><identifier>ISSN: 0899-9007</identifier><identifier>EISSN: 1873-1244</identifier><identifier>DOI: 10.1016/j.nut.2021.111581</identifier><identifier>PMID: 35101812</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>AA/EPA ratio ; Applied Nutritional Investigation ; Arachidonic acid ; Cell membranes ; Chromatography ; Composition ; Coronaviruses ; Correlation ; COVID-19 ; Cytokine storm ; Cytokines ; Dimers ; Eicosanoids ; Erythrocyte Membrane ; Erythrocytes ; Fatty Acids ; Fatty Acids, Omega-3 ; g-linolenic acid ; Humans ; IL-6 ; Immunoassay ; Immunoregulation ; Infections ; Inflammation ; Interleukin 6 ; Linolenic acid ; Mortality ; Mucosa ; Polyunsaturated fatty acids ; Procalcitonin ; Prognosis ; PUFAs ; Sepsis ; Severe acute respiratory syndrome coronavirus 2 ; Statistical analysis ; Viral diseases ; ω-6/ω-3 ratio</subject><ispartof>Nutrition (Burbank, Los Angeles County, Calif.), 2022-04, Vol.96, p.111581-111581, Article 111581</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Apr 2022</rights><rights>2021 Published by Elsevier Inc. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-8df144c5e906b81074cc2fb60455762513e19892cf38ff27f10e5ef263f5dcdc3</citedby><cites>FETCH-LOGICAL-c479t-8df144c5e906b81074cc2fb60455762513e19892cf38ff27f10e5ef263f5dcdc3</cites><orcidid>0000-0002-4414-9224</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2637310046?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35101812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sertoglu, Erdim</creatorcontrib><creatorcontrib>Yucel, Cigdem</creatorcontrib><creatorcontrib>Balık, Ahmet Rıfat</creatorcontrib><creatorcontrib>Taşçı, Cantürk</creatorcontrib><creatorcontrib>Bilge, Sedat</creatorcontrib><creatorcontrib>Ertuğrul, Meryem Sebla</creatorcontrib><creatorcontrib>Nazaroğlu, Namık Kemal</creatorcontrib><creatorcontrib>Ozgurtas, Taner</creatorcontrib><title>Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19</title><title>Nutrition (Burbank, Los Angeles County, Calif.)</title><addtitle>Nutrition</addtitle><description>•Polyunsaturated fatty acids and the ratio of arachidonic acid to eicosopentaenoic acid, like interleukin-6, are markers of inflammation in people with COVID-19.•The ratio of arachidonic acid to eicosopentaenoic acid showed a significant positive correlation with only interleukin-6.•Levels of γ-linolenic acid and the ω-6/ω-3 ratio were significantly increased in all comparison groups.•The ω-3 index showed a moderately negative correlation with interleukin-6. The cytokine storm presented in the hyperimmune response is related to poor prognosis in people with COVID-19. Interleukin-6 (IL-6) is one of the most prominent cytokines, especially on mucosal surfaces during infection, causing the cytokine storm. Polyunsaturated fatty acids (PUFAs) are the precursors of eicosanoids, which play critical roles in immune regulation and inflammation. The balance between ω-3 and ω-6 levels in the cell membrane has a critical role in regulating the equilibrium between proinflammatory and antiinflammatory processes and inducing IL-6 production. The present study focused on inflammatory and antiinflammatory mechanisms in COVID-19 over PUFAs and on relating their levels with disease prognosis and severity. A total of 106 participants were included in the study. They were divided into three groups according to IL-6 level— 1: &lt;35 pg/mL, 2: between 35 and 300 pg/mL, and 3: &gt;300 pg/mL. Erythrocyte membrane PUFA compositions were analyzed by group. Levels of γ-linolenic acid and ω-6/ω-3 ratios were significantly increased in all comparison groups (P &lt; 0.05). Total ω-6 and the ratio of arachidonic acid to eicosopentaenoic acid showed a statistically significant difference only between groups 1 and 3 (P &lt; 0.05). There was a moderately negative correlation between total ω-3 and IL-6 and procalcitonin. There were positive correlations with ω-6/ω-3 ratio inflammatory markers, and the total ω-6 index also showed a moderately positive correlation with IL-6, procalcitonin, and D-dimer levels. The ratio of arachidonic acid to eicosopentaenoic acid, and ω-3 PUFAs, can be systemic signs of poor prognosis, increased lung damage, and high mortality in COVID-19, together with IL-6.</description><subject>AA/EPA ratio</subject><subject>Applied Nutritional Investigation</subject><subject>Arachidonic acid</subject><subject>Cell membranes</subject><subject>Chromatography</subject><subject>Composition</subject><subject>Coronaviruses</subject><subject>Correlation</subject><subject>COVID-19</subject><subject>Cytokine storm</subject><subject>Cytokines</subject><subject>Dimers</subject><subject>Eicosanoids</subject><subject>Erythrocyte Membrane</subject><subject>Erythrocytes</subject><subject>Fatty Acids</subject><subject>Fatty Acids, Omega-3</subject><subject>g-linolenic acid</subject><subject>Humans</subject><subject>IL-6</subject><subject>Immunoassay</subject><subject>Immunoregulation</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Linolenic acid</subject><subject>Mortality</subject><subject>Mucosa</subject><subject>Polyunsaturated fatty acids</subject><subject>Procalcitonin</subject><subject>Prognosis</subject><subject>PUFAs</subject><subject>Sepsis</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Statistical analysis</subject><subject>Viral diseases</subject><subject>ω-6/ω-3 ratio</subject><issn>0899-9007</issn><issn>1873-1244</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kUFv1DAQhS1ERZfCD-CCInHhkq3HcZxYSEhoW6BSpV6Aq-V1xqyXJF5sZ6s99L_XS0oFHDhZGn_vaeY9Ql4BXQIFcb5djlNaMspgCQB1C0_IAtqmKoFx_pQsaCtlKSltTsnzGLeUUpBCPiOnVZ31LbAFubvc637Syfmx8LbAcEib4M0hYTHgsA56xMLqlA6lNq4rjB92ProjHgs3FjpGb9wsv3Vpk2cJQ4_TDzeWouhxj_0vcJcZHFOcqdXNt6uLEuQLcmJ1H_Hlw3tGvn68_LL6XF7ffLpafbguDW9kKtvOAuemRknFugXacGOYXQvK67oRrIYKQbaSGVu11rLGAsUaLROVrTvTmeqMvJ99d9N6wM7kTYLu1S64QYeD8tqpv39Gt1Hf_V61DVDGIRu8fTAI_ueEManBRYN9n_PxU1RMMC4EBS4z-uYfdOunMObzMlU1FVDKRaZgpkzwMQa0j8sAVcdy1VblctWxXDWXmzWv_7ziUfG7zQy8m4EcOu4dBhVNTt1g5wKapDrv_mN_D7eUtus</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Sertoglu, Erdim</creator><creator>Yucel, Cigdem</creator><creator>Balık, Ahmet Rıfat</creator><creator>Taşçı, Cantürk</creator><creator>Bilge, Sedat</creator><creator>Ertuğrul, Meryem Sebla</creator><creator>Nazaroğlu, Namık Kemal</creator><creator>Ozgurtas, Taner</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>Published by Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7RV</scope><scope>7TS</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4414-9224</orcidid></search><sort><creationdate>20220401</creationdate><title>Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19</title><author>Sertoglu, Erdim ; Yucel, Cigdem ; Balık, Ahmet Rıfat ; Taşçı, Cantürk ; Bilge, Sedat ; Ertuğrul, Meryem Sebla ; Nazaroğlu, Namık Kemal ; Ozgurtas, Taner</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-8df144c5e906b81074cc2fb60455762513e19892cf38ff27f10e5ef263f5dcdc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>AA/EPA ratio</topic><topic>Applied Nutritional Investigation</topic><topic>Arachidonic acid</topic><topic>Cell membranes</topic><topic>Chromatography</topic><topic>Composition</topic><topic>Coronaviruses</topic><topic>Correlation</topic><topic>COVID-19</topic><topic>Cytokine storm</topic><topic>Cytokines</topic><topic>Dimers</topic><topic>Eicosanoids</topic><topic>Erythrocyte Membrane</topic><topic>Erythrocytes</topic><topic>Fatty Acids</topic><topic>Fatty Acids, Omega-3</topic><topic>g-linolenic acid</topic><topic>Humans</topic><topic>IL-6</topic><topic>Immunoassay</topic><topic>Immunoregulation</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Linolenic acid</topic><topic>Mortality</topic><topic>Mucosa</topic><topic>Polyunsaturated fatty acids</topic><topic>Procalcitonin</topic><topic>Prognosis</topic><topic>PUFAs</topic><topic>Sepsis</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Statistical analysis</topic><topic>Viral diseases</topic><topic>ω-6/ω-3 ratio</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sertoglu, Erdim</creatorcontrib><creatorcontrib>Yucel, Cigdem</creatorcontrib><creatorcontrib>Balık, Ahmet Rıfat</creatorcontrib><creatorcontrib>Taşçı, Cantürk</creatorcontrib><creatorcontrib>Bilge, Sedat</creatorcontrib><creatorcontrib>Ertuğrul, Meryem Sebla</creatorcontrib><creatorcontrib>Nazaroğlu, Namık Kemal</creatorcontrib><creatorcontrib>Ozgurtas, Taner</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career &amp; Technical Education Database</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nutrition (Burbank, Los Angeles County, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sertoglu, Erdim</au><au>Yucel, Cigdem</au><au>Balık, Ahmet Rıfat</au><au>Taşçı, Cantürk</au><au>Bilge, Sedat</au><au>Ertuğrul, Meryem Sebla</au><au>Nazaroğlu, Namık Kemal</au><au>Ozgurtas, Taner</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19</atitle><jtitle>Nutrition (Burbank, Los Angeles County, Calif.)</jtitle><addtitle>Nutrition</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>96</volume><spage>111581</spage><epage>111581</epage><pages>111581-111581</pages><artnum>111581</artnum><issn>0899-9007</issn><eissn>1873-1244</eissn><abstract>•Polyunsaturated fatty acids and the ratio of arachidonic acid to eicosopentaenoic acid, like interleukin-6, are markers of inflammation in people with COVID-19.•The ratio of arachidonic acid to eicosopentaenoic acid showed a significant positive correlation with only interleukin-6.•Levels of γ-linolenic acid and the ω-6/ω-3 ratio were significantly increased in all comparison groups.•The ω-3 index showed a moderately negative correlation with interleukin-6. The cytokine storm presented in the hyperimmune response is related to poor prognosis in people with COVID-19. Interleukin-6 (IL-6) is one of the most prominent cytokines, especially on mucosal surfaces during infection, causing the cytokine storm. Polyunsaturated fatty acids (PUFAs) are the precursors of eicosanoids, which play critical roles in immune regulation and inflammation. The balance between ω-3 and ω-6 levels in the cell membrane has a critical role in regulating the equilibrium between proinflammatory and antiinflammatory processes and inducing IL-6 production. The present study focused on inflammatory and antiinflammatory mechanisms in COVID-19 over PUFAs and on relating their levels with disease prognosis and severity. A total of 106 participants were included in the study. They were divided into three groups according to IL-6 level— 1: &lt;35 pg/mL, 2: between 35 and 300 pg/mL, and 3: &gt;300 pg/mL. Erythrocyte membrane PUFA compositions were analyzed by group. Levels of γ-linolenic acid and ω-6/ω-3 ratios were significantly increased in all comparison groups (P &lt; 0.05). Total ω-6 and the ratio of arachidonic acid to eicosopentaenoic acid showed a statistically significant difference only between groups 1 and 3 (P &lt; 0.05). There was a moderately negative correlation between total ω-3 and IL-6 and procalcitonin. There were positive correlations with ω-6/ω-3 ratio inflammatory markers, and the total ω-6 index also showed a moderately positive correlation with IL-6, procalcitonin, and D-dimer levels. The ratio of arachidonic acid to eicosopentaenoic acid, and ω-3 PUFAs, can be systemic signs of poor prognosis, increased lung damage, and high mortality in COVID-19, together with IL-6.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35101812</pmid><doi>10.1016/j.nut.2021.111581</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4414-9224</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0899-9007
ispartof Nutrition (Burbank, Los Angeles County, Calif.), 2022-04, Vol.96, p.111581-111581, Article 111581
issn 0899-9007
1873-1244
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8710241
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects AA/EPA ratio
Applied Nutritional Investigation
Arachidonic acid
Cell membranes
Chromatography
Composition
Coronaviruses
Correlation
COVID-19
Cytokine storm
Cytokines
Dimers
Eicosanoids
Erythrocyte Membrane
Erythrocytes
Fatty Acids
Fatty Acids, Omega-3
g-linolenic acid
Humans
IL-6
Immunoassay
Immunoregulation
Infections
Inflammation
Interleukin 6
Linolenic acid
Mortality
Mucosa
Polyunsaturated fatty acids
Procalcitonin
Prognosis
PUFAs
Sepsis
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Viral diseases
ω-6/ω-3 ratio
title Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A41%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20erythrocyte%20membrane%20fatty-acid%20compositions%20in%20association%20with%20interleukin-6%20levels%20in%20patients%20with%20COVID-19&rft.jtitle=Nutrition%20(Burbank,%20Los%20Angeles%20County,%20Calif.)&rft.au=Sertoglu,%20Erdim&rft.date=2022-04-01&rft.volume=96&rft.spage=111581&rft.epage=111581&rft.pages=111581-111581&rft.artnum=111581&rft.issn=0899-9007&rft.eissn=1873-1244&rft_id=info:doi/10.1016/j.nut.2021.111581&rft_dat=%3Cproquest_pubme%3E2624660149%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2637310046&rft_id=info:pmid/35101812&rft_els_id=S0899900721004433&rfr_iscdi=true